点击蓝字关注我们【导读】包括肿瘤异质性和 T 细胞浸润不足在内的各种挑战阻碍了嵌合抗原受体 T 细胞（CAR-T）疗法在胶质母细胞瘤（GBM）治疗中的进展。3月20日，山东大学齐鲁医学院研究人员在期刊《Advanced ...

胶质母细胞瘤（Glioblastoma, ...

Glioblastoma has remained one of the toughest cancers to treat, resisting even the latest advances in immunotherapy. But new ...

INAB READ THE FULL INAB RESEARCH REPORT Following the announcement of its new γδ T cell engager platform INB-600, IN8bio, Inc ...

Glioblastoma has long resisted treatment, but scientists may have found a breakthrough by leveraging the body's own ...

UCLA scientists have identified a potential new strategy for treating glioblastoma, the deadliest form of brain cancer, by reprogramming aggressive cancer cells into harmless ones. When tested in ...

In experiments conducted at the University of São Paulo, tumor stem cells became less able to proliferate and invade tissues ...

Suppressing the ZNF638 protein tricks the body into attacking glioblastoma , a potential breakthrough in brain cancer therapy ...

Brain Tumor Organoids Accurately Model Patient Response to CAR T Cell Therapy Dec. 9, 2024 — Researchers used lab-grown organoids created from tumors of individuals with glioblastoma (GBM ...

Scientists at UCLA have discovered a potential new way to treat glioblastoma, the most aggressive type of brain cancer. Their ...